Intraperitoneal administration of concanavalin A (ConA, 25 mg/kg b.w.), a cell-binding plant lectin was used for inducing infl ammatory ascites, and potential inhibitors were tested in 1 h and 2.5 h experiments, i.e. still before the major infl ux of leucocytes. At the end of the experiment the peritoneal fl uid was collected and measured.
Introduction
The peritoneal fl uid originates mainly from the subperitoneal vessels of the intestines and provides lubrication for the movement of abdominal organs. The excess fl uid is returned to the lymphatics through the lymphatic stomata [1] , lo-cated mainly at the diaphragm. Introduced substances may be absorbed also across the mesothelial lining.
The large molecules, due to their slow peritoneal absorption, are more suitable for the study of ascites induction, than the small ones. In an earlier study [2] a screening of inducer macromolecules was performed. Three groups of compounds were effective, namely the cell-surface binding lectines, the polykations (polyLys, polyArg and polyethyleneimine) and a heterogeneous group of polysaccharides, e.g. the well-known infl ammatory agents zymosan and carrageenan.
In the present work the ConA, a tetravalent, mannose/glucose specifi c, cell binding plant lectin [3] was used for the routine induction of infl ammatory ascites to test various compounds for inhibitory activity. The results indicate the contribution of the kallikrein/kinin system to the mediation of the ConA induced ascites.
Materials and Methods
The chemicals were Sigma products, except the Kunitz-type soyabean trypsin inhibitor (Reanal). The agents were dissolved in physiological saline, the ConA always freshly. MK886 was fi rst dissolved with a drop of ethanol, then fi lled up with saline to the required volume.
Animals: Female, 24 g NMRI mice of SPF origin were kept in cages and had free access to commercial chow and water. Protocol: The animals were used in groups of fi ve or six, except mentioned. Both i.p. and s.c. injections were administered in 0.1 ml volume. Infl ammatory ascites was induced by injecting ConA (25 mg/kg b.w.) intraperitoneally with or without inhibitor. One or 2.5 h later the animals were decapitated under ether anaesthesia, the abdomen was opened along the linea alba, and the ascitic fl uid was carefully collected with a pipette, always performed by the same person. The volume was measured by pipetting the fl uid into another vessel and expressed as % of body weight. Blood-stained samples were discarded.
Aprotinin (in the 2.5 h experiment), fetuin and icatibant were administered mixed with the ConA inducer. Other inhibitors were injected s.c., 20 min before the induction. In the 2.5 h experiment half of the L-NAME dose was added before the induction by ConA and the other half 1 h later.
Statistics: Signifi cance of differences was calculated with ANOVA of the SPSS program.
Results
I.p. injection of 0.1 ml of physiological saline was used as a negative control. Due to the absorption of the saline, this control produced very low peritoneal fl uid volumes, which could not be exactly measured, and were not considered.
I.p. administered ConA (25 mg/kg b.w.) was used as positive control. Its repetition did not produce signifi cant differences. The same treatment was used routinely in the experiments with inhibitors. In the icatibant study another ConA charge with slightly lower activity was used.
In the 2.5 h experiment ( Figure 1 ) fetuin (75 mg/kg b.w.), atropine methylnitrate (0.4 mg/kg), L-NAME (N-nitro-L-arginine-methyl-esther. HCl, 30 mg/kg) and aprotinin (a trypsin and kallikrein inhibitor protein, 100 mg/kg) were tested In the 1 h experiment (Fig. 2 ) two treatments were repeated with similar results as before: aprotinin (100 mg/kg) was markedly inhibitory (p<0.01), and L-NAME (20 mg/kg) was ineffective. Three additional compounds exerted slight inhibitory effect (p<0.05), namely, the Kunitz (100 mg/kg) and Bowman-Birk (100 mg/kg) trypsin inhibitors of the soyabean, and a leukotriene synthesis inhibitor (MK886, 3 mg/kg).
In a third experiment (Fig. 3 ) icatibant acetate (HOE-140), a bradykinin receptor antagonist polypeptide was tested, and highly signifi cant (p<0.01) inhibition of fl uid accumulation was observed at both 5 and 25 mg/kg b.w. dose level.
Discussion
In an earlier study a wide range of macromolecules was screened for the ability to induce infl ammatory ascites [2] , still before the major infl ux of leukocytes [4] . In further studies ConA was chosen for routine induction of ascites to clarify the mechanism of the process. Histamine was excluded as mediator [5] . Next we applied other potential inhibitors of ascites formation to obtain indirect information about the mediators. In a preliminary screening thalidomide (NFκB inhibitor), captopril (ACE-and tissue metalloproteinase inhibitor) and ZM323881 (VEGF receptor antagonist) had no inhibitory effect (unpublished). In the present work conclusions were drawn only if the differences reached the 1% confi dence level as compared to the positive control group (ConA alone).
In both the 2.5 h and 1 h experiments (Figs. 1 and 2) high aprotinin dose (100 mg/kg b.w.) was required for signifi cant (p<0.01) inhibition of ConA-induced ascites. The bradykinin receptor antagonist icatibant was more effective than aprotinin and produced dose-dependent inhibition (p<0.01, Fig. 3 ). It is concluded that the kallikrein/kinin system contributed to the mediation of the ConA-induced ascites via the B2 receptor. The role of the inducible B1 receptor can be excluded, because of the short duration of the present experiments. The fi ndings are in agreement with the ascites-inducing role of kallikrein in the ovarian hyperstimulation syndrome [6] .
In the present work complete inhibition of ConA-induced ascites could not be achieved, which indicates the involvement of additional mediators.
It is known that bradykinin produces vasodilatation by the activation of eNOS. However, the inhibition of NO synthesis by L-NAME ( Figs. 1 and 2) did not affect the ConA-induced ascites. Permeability of subperitoneal capillaries may be controlled by Ca 2+ infl ux, another effect of bradykinin [7] . The native, tetravalent ConA makes non-covalent cross-links between the glycosyl side-chains of cell surface glycoproteins resulting in their aggregation [8] . The monovalent succinyl-ConA is ineffective [2] . The distortion of membrane structure may activate membrane prekallikrein [9] resulting in the release of kinins. Cellular mediation of the ConA-induced ascites is beyond the scope of the present paper.
In spite of being trypsin-like proteinases, kallikreins are not inhibited by the trypsin inhibitors of the soyabean. However, both Kunitz and BowmanBirk inhibitors exerted a small, but signifi cant (p<0.05) effect on the ConAinduced ascites (Fig. 2) .
Parasympathic mediation was excluded, using atropine methylnitrate ( Fig. 1) , a molecular variant without central effect.
Fetuin is a mannose-containing, heavily glycosylated serum protein. When injected in threefold excess (by weight) of ConA, it exerted slight but signifi cant (p<0.05) inhibitory effect on the accumulation of peritoneal fl uid (Fig. 1) . Although the mannose residue directly reacts with the functional moiety of the ConA molecule, in vivo the lectins are transposed to the cell membrane receptors [2] , which may explain the poor inhibitory effect of fetuin.
